close
close
migores1

Zacks Research Commentary on Patterson Companies, Inc.’s Q2 2025 Earnings. (NASDAQ:PDCO)

Patterson Companies, Inc. (NASDAQ:PDCO – Free Report) – Research analysts at Zacks Research decreased their Q2 2025 EPS estimates for shares of Patterson Companies in a note issued to investors on Tuesday, September 10th. Zacks Research analyst I. Bandyopadhyay now anticipates that the company will post earnings of $0.50 per share for the quarter, down from their prior estimate of $0.53. The consensus estimate for Patterson Companies current earnings for the full year is $2.33 per share. Zacks Research also issued estimates for Patterson Companies Q3 2025 earnings at $0.65 EPS, Q1 2026 earnings at $0.28 EPS, Q2 2026 earnings at $0.48 EPS and Q1 2027 earnings at $0.32. USD EPS.

Several other equities research analysts have also recently weighed in on the stock. StockNews.com lowered shares of Patterson Companies from a “buy” rating to a “hold” rating in a research report on Saturday, June 1st. Morgan Stanley lowered their price objective on shares of Patterson Companies from $30.00 to $28.00 and set an “equal weight” rating for the company in a research report on Thursday, June 20th. UBS Group cut their price target on Patterson Companies from $27.00 to $24.00 and set a “neutral” rating on the stock in a report on Thursday, September 5th. Bank of America cut their price target on Patterson Companies from $31.00 to $29.00 and set a “buy” rating for the company in a report on Thursday, August 29th. Finally, Robert W. Baird reduced their price objective on Patterson Companies from $30.00 to $28.00 and set a “neutral” rating on the stock in a research note on Thursday, 29 August. Nine analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $28.40.

Want more great investment ideas?

Get the latest PDCO report

Stock performance of Patterson Companies

PDCO opened at $21.09 on Thursday. The company has a debt-to-equity ratio of 0.34, a quick ratio of 0.67, and a current ratio of 1.30. Patterson Companies has a 52-week low of $19.96 and a 52-week high of $32.58. The firm has a market cap of $1.85 billion, a P/E ratio of 10.55, a price-to-earnings-growth ratio of 1.50 and a beta of 1.02. The company’s fifty day moving average is $24.04 and its 200 day moving average is $25.04.

Patterson Companies (NASDAQ:PDCO – Get Free Report ) last posted its quarterly earnings results on Wednesday, August 28th. The company reported $0.24 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.32 by ($0.08). Patterson Companies had a net margin of 2.58% and a return on equity of 19.87%. The company had revenue of $1.54 billion during the quarter, compared to the consensus estimate of $1.59 billion. In the same quarter last year, the company posted earnings of $0.40 per share. The company’s quarterly revenue was down 2.3% year-over-year.

Insider activity at Patterson Companies

In other news, CEO Donald Zurbay sold 5,875 shares of Patterson Companies stock in a transaction dated Wednesday, July 3rd. The shares were sold at an average price of $23.71, for a total transaction of $139,296.25. Following the transaction, the chief executive officer now owns 237,288 shares in the company, valued at $5,626,098.48. The sale was disclosed in a filing with the SEC, which is available on the SEC’s website. In related news, CEO Donald Zurbay sold 5,875 shares of Patterson Companies stock in a transaction that occurred on Wednesday, July 3rd. The stock was sold at an average price of $23.71, for a total value of $139,296.25. Following the transaction, the chief executive officer now directly owns 237,288 shares of the company’s stock, valued at $5,626,098.48. The transaction was disclosed in a legal filing with the SEC, which is available via this hyperlink. Also, CFO Kevin Michael Barry sold 1,216 shares of the stock in a transaction that occurred on Wednesday, July 3rd. The shares were sold at an average price of $23.72, for a total transaction of $28,843.52. Following the sale, the chief financial officer now directly owns 41,605 shares of the company’s stock, valued at approximately $986,870.60. The disclosure for this sale can be found here. Insiders sold a total of 17,149 shares of company stock valued at $415,851 over the last quarter. 1.50% of the stock is owned by insiders.

Patterson Companies Institutional Trading

A number of institutional investors have recently bought and sold shares of PDCO. Sanctuary Advisors LLC purchased a new position in Patterson Companies in the second quarter valued at about $429,000. Aristides Capital LLC bought a new stake in shares of Patterson Companies in the second quarter valued at $246,000. Point72 Asset Management LP boosted its stake in Patterson Companies by 1,574.9% in the second quarter. Point72 Asset Management LP now owns 340,000 shares of the company’s stock valued at $8,201,000 after acquiring an additional 319,700 shares during the last quarter. Algert Global LLC purchased a new position in shares of Patterson Companies in the second quarter valued at $1,939,000. Finally, Scientech Research LLC boosted its stake in Patterson Companies by 30.2% in the second quarter. Scientech Research LLC now owns 11,697 shares of the company’s stock worth $282,000 after acquiring an additional 2,714 shares during the last quarter. Institutional investors own 85.43% of the company’s shares.

Patterson Companies Company Profile

(Get a free report)

Patterson Companies, Inc is engaged in the distribution of dental and animal health products in the United States, United Kingdom and Canada. The company operates through three segments: Dental, Animal Health and Corporate. The Dental segment offers consumable products, including infection control, restorative materials and instruments; basic and advanced dental technology and equipment; practice optimization solutions such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems.

Featured stories

Earnings History and Estimates for Patterson Companies (NASDAQ:PDCO)

Receive daily news and ratings for Patterson companies – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Patterson Companies and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Articles

Back to top button